EichorEICHOR
Location: Fountain Valley Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Fountain Valley

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Phase 3 · Ark Clinical Research - Fountain Valley · Eli Lilly and Company · NCT07353931BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer
Phase 3 · Helios Clinical Research the Oncology Institute Fountain Val · BeOne Medicines · NCT07492641A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Ark Clinical Research - Fountain Valley · Eli Lilly and Company · NCT07420283A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associa
Phase 2 · Ark Clinical Research - Fountain Valley · Regeneron Pharmaceuticals · NCT05519475Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-sm
Phase 3 · Orange Coast Memorial Medical Center Fountain Valley · Daiichi Sankyo · NCT06899126A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participant
Phase 3 · AbbVie · NCT05889182MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase N/A · Premier Surgery Center · Stryker Instruments · NCT03072927Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Phase 3 · First OC Dermatology - Fountain Valley · Bristol-Myers Squibb · NCT07116967A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) In
Phase 2 · ARK Clinical Research - Fountain Valley · Eccogene · NCT07288138Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Phase 3 · Ark Clinical Research - Fountain Valley · Eli Lilly and Company · NCT07157774Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adu
Phase 3 · Memorial Care Orange Coast Medical Center Attn · Pfizer · NCT07222566Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Phase 2 · Ark Clinical Research - Fountain Valley · Sparrow Pharmaceuticals · NCT07296484A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Ou
Phase 3 · Ark Clinical Research - Fountain Valley · Eli Lilly and Company · NCT07165028A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Phase 3 · Ark Clinical Research - Fountain Valley · Eli Lilly and Company · NCT07321886
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.